© Golden Shrimp/Dreamstime
Moderna Covid 19 Vaccine Vials Pharmaceuticals © Golden Shrimp Dreamstime
Moderna Covid 19 Vaccine Vials Pharmaceuticals © Golden Shrimp Dreamstime
Moderna Covid 19 Vaccine Vials Pharmaceuticals © Golden Shrimp Dreamstime
Moderna Covid 19 Vaccine Vials Pharmaceuticals © Golden Shrimp Dreamstime
Moderna Covid 19 Vaccine Vials Pharmaceuticals © Golden Shrimp Dreamstime

US Drug Maker Moderna Opening Vaccine Plant in Canada

Aug. 11, 2021
Canada currently has no domestic vaccine production, and so has depended on imports of Pfizer-BioNTech, Moderna and other jabs to inoculate its 38 million people against the novel coronavirus.

U.S. biotech company Moderna will build a plant in Canada to produce vaccines for COVID-19 and other respiratory infections, the Canadian government and the company announced Tuesday.

Industry Minister Francois-Philippe Champagne made the announcement with the head of Moderna, saying the plant would fulfill orders for its messenger RNA vaccines, with manufacturers struggling to meet soaring demand for Covid-19 shots worldwide.

"The collaboration aims to provide Canadians with access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses, including Covid-19, seasonal influenza, respiratory syncytial virus (RSV) and potential other vaccines," the company said in a statement.

"If there is a new virus emerging -- a new string of Zika or Ebola or corona or flu, the Canadian government can decide to use part or all of that capacity for that specific virus to protect the Canadian people," said Champagne. 

The government's financial contribution to the project was not disclosed. But the company, according to Champagne, is investing "several hundred million dollars" in the state of the art facility.

Canada currently has no domestic vaccine production, and so has depended on imports of Pfizer-BioNTech, Moderna and other jabs to inoculate its 38 million people against the novel coronavirus.

In May, it invested nearly Can$200 million to expand Resilience Biotechnologies' vaccine plant in Mississauga, Ontario, and earmarked Can$2.2 billion in its spring budget to boost its biomanufacturing and life sciences sector.

French pharmaceutical giant Sanofi and Canadian biotech firm Medicago were among the first to receive Canadian funding to develop vaccines and eventually produce shots locally too.

Moderna chief executive Stephane Bancel said its new facility would be up and running by 2024, producing initially up to 30 million vaccine doses per year.

"In the last six to nine months... dozens of countries have contacted us to build factories on their soil. The country that has been the fastest to move... has been Canada," he said.

"We anticipate to build more factories around the world using a similar model."

Copyright Agence France-Presse, 2021

Popular Sponsored Recommendations

Lufthansa Technik Soars to New Heights in Manufacturing and Service by Implementing a Digital Thread

Feb. 22, 2024
Learn how Lufthansa Technik is leveraging digitalization to find efficiencies to keep costs down, while keeping customer satisfaction high & increasing quality.

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

The Ultimate Guide for Surviving Economic Uncertainty & Supply Chain Disruption

March 13, 2024
Are disruptive external forces putting a squeeze on your supply chain? Nulogy can help. Access our Survival Guide to uncover 5 critical areas of investment for external supply...

Cloud-Based OT Data Management to Enable Analytics & Optimization

April 9, 2023
Can you rapidly move all of your company's OT data to the cloud at scale at a reasonable cost? Read the white paper to find out how!

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!